Table 1.

Correlation between MT1G methylation levels and clinicopathological features in liver cancer data from TCGA

	Low methylation		High methylation
Variable	(n = 127)	%	(n = 125)	%	p-value
Age
< 60	58	47.5%	64	52.5%	0.380
≥ 60	69	53.1%	61	46.9%
Gender
Male	99	55.6%	79	44.4%	0.010
Female	28	37.8%	46	62.2%
Family history
of cancer
Yes	42	48.8%	44	51.2%	0.722
No	85	51.2%	81	48.8%
Alcohol consumption
Yes	45	50.6%	44	49.4%	0.969
No	82	50.3%	81	49.7%
HBV/HCV infection
Yes	59	50.9%	57	49.1%	0.891
No	68	50.0%	68	50.0%
Non-alcoholic fatty liver disease
Yes	4	26.7%	11	73.3%	0.058
No	123	51.9%	114	48.1%
Tumor stage
I & II	91	49.7%	92	50.3%	0.729
III & IV	36	52.2%	33	47.8%
Recurrence
Yes	72	51.8%	67	48.2%	0.622
No	55	48.7%	58	51.3%